Our findings from this current study suggests that a treatment regimen involving replacement of the downregulated miRNAs with functional miRNA mimics may potentially be the key to further sensitise MPM tumours to FAK inhibitor treatment and warrants further investigation in prospective preclinical and clinical studies of MPM. Here, PTK2 is linked to neoplasm.